Literature DB >> 10691795

Abnormal pressure-natriuresis in hypertension: role of nitric oxide.

J P Granger1, B T Alexander.   

Abstract

The kidneys have a critical role in long-term control of arterial pressure by regulating extracellular fluid and plasma volume. According to the renal body fluid feedback mechanism for long-term control, persistent hypertension can only occur as a result of a reduction in renal sodium excretory function or a hypertensive shift in the pressure-natriuresis relationship. Although an abnormal relationship between renal perfusion pressure and renal sodium excretion has been identified in every type of hypertension where it has been sought, factors responsible for this effect are still unclear. Nitric oxide (NO) is produced within the kidney and plays an important role in the control of many intrarenal processes which regulate the renal response to changes in perfusion pressure and thus, help determine plasma volume and blood pressure. Numerous studies have shown that long-term inhibition of NO synthesis results in a chronic rightward shift and marked attenuation in renal pressure-natriuresis. Recent studies have shown that certain animal models of genetic hypertension and forms of human hypertension areas are associated with a decrease in NO synthesis. Reductions in NO synthesis reduces renal sodium excretory function not only through direct actions on the renal vasculature, but through modulation of other vasoconstrictor processes and through direct and indirect alterations in tubular sodium transport. The causes and consequences of the dysregulation of NO in hypertension and other renal disease processes remain an important area of investigation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10691795     DOI: 10.1046/j.1365-201x.2000.00655.x

Source DB:  PubMed          Journal:  Acta Physiol Scand        ISSN: 0001-6772


  13 in total

Review 1.  Mechanisms of pressure natriuresis.

Authors:  Joey P Granger; Barbara T Alexander; Mayte Llinas
Journal:  Curr Hypertens Rep       Date:  2002-04       Impact factor: 5.369

2.  Angiotensin II-induced hypertension blunts thick ascending limb NO production by reducing NO synthase 3 expression and enhancing threonine 495 phosphorylation.

Authors:  Vanesa D Ramseyer; Agustin Gonzalez-Vicente; Oscar A Carretero; Jeffrey L Garvin
Journal:  Am J Physiol Renal Physiol       Date:  2014-11-05

Review 3.  Examining the safety profile of angiogenesis inhibitors: implications for clinical practice.

Authors:  Martin Reck
Journal:  Target Oncol       Date:  2010-09-15       Impact factor: 4.493

Review 4.  Reactive oxygen species as important determinants of medullary flow, sodium excretion, and hypertension.

Authors:  Allen W Cowley; Michiaki Abe; Takefumi Mori; Paul M O'Connor; Yusuke Ohsaki; Nadezhda N Zheleznova
Journal:  Am J Physiol Renal Physiol       Date:  2014-10-29

5.  A novel lipid natriuretic factor in the renal medulla: sphingosine-1-phosphate.

Authors:  Qing Zhu; Min Xia; Zhengchao Wang; Pin-Lan Li; Ningjun Li
Journal:  Am J Physiol Renal Physiol       Date:  2011-04-06

6.  Small Amounts of Inorganic Nitrate or Beetroot Provide Substantial Protection From Salt-Induced Increases in Blood Pressure.

Authors:  R Curtis Morris; Michal Pravenec; Jan Šilhavý; Stephen E DiCarlo; Theodore W Kurtz
Journal:  Hypertension       Date:  2019-05       Impact factor: 10.190

7.  Angiotensin II decreases nitric oxide synthase 3 expression via nitric oxide and superoxide in the thick ascending limb.

Authors:  Vanesa D Ramseyer; Jeffrey L Garvin
Journal:  Hypertension       Date:  2008-12-15       Impact factor: 10.190

8.  Effects of hyperhomocysteinemia on arterial pressure and nitric oxide production in pregnant rats.

Authors:  Derrick L Chandler; Maria T Llinas; Jane F Reckelhoff; Babbette LaMarca; Joshua Speed; Joey P Granger
Journal:  Am J Hypertens       Date:  2009-07-23       Impact factor: 2.689

9.  Role of caveolin 1 in AT1a receptor-mediated uptake of angiotensin II in the proximal tubule of the kidney.

Authors:  Xiao C Li; Victor Gu; Elise Miguel-Qin; Jia L Zhuo
Journal:  Am J Physiol Renal Physiol       Date:  2014-08-27

10.  Resveratrol did not alter blood pressure in rats with nitric oxide synthase-inhibited hypertension.

Authors:  Mehmet Aydin; Buket Gungor; A Secil Akdur; Hakki Engin Aksulu; Coskun Silan; Ibrahim Susam; Ali Kemal Cabuk; Gizem Cabuk
Journal:  Cardiovasc J Afr       Date:  2017 May/Jun       Impact factor: 1.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.